First evidence for the antitumor activity of nanoliposomal irinotecan with 5-fluorouracil and folinic acid in metastatic biliary tract cancer

被引:0
作者
Hossein Taghizadeh
Matthias Unseld
Andreas Schmiderer
Angela Djanani
Klaus Wilthoner
Dieter Buchinger
Gerald W. Prager
机构
[1] Medical University of Vienna,Clinical Division of Oncology, Department of Medicine I
[2] Comprehensive Cancer Center,Clinical Division of Gastroenterology, Hepatology and Metabolism, Department of Internal Medicine I
[3] Medical University Innsbruck,Clinical Division of Oncology, Department of Medicine I
[4] Salzkammergut Klinikum,undefined
来源
Cancer Chemotherapy and Pharmacology | 2020年 / 86卷
关键词
Biliary tract cancer; Chemotherapy; Nanoliposomal irinotecan; Progression-free survival; Overall survival;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:109 / 115
页数:6
相关论文
共 50 条
  • [41] Irinotecan combined with 5-fluorouracil and leucovorin as second-line chemotherapy for metastatic or relapsed gastric cancer
    Seo, Myung-Deok
    Lee, Keun-Wook
    Lim, Joo Han
    Yi, Hyeon Gyu
    Kim, Dae-Young
    Oh, Do-Youn
    Kim, Jee Hyun
    Im, Seock-Ah
    Kim, Tae-You
    Lee, Jong Seok
    Bang, Yung-Jue
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 38 (09) : 589 - 595
  • [42] Colon Cancer Cells Gene Expression Signature As Response to 5-Fluorouracil, Oxaliplatin, and Folinic Acid Treatment
    Negrei, Carolina
    Hudita, Ariana
    Ginghina, Octav
    Galateanu, Bianca
    Voicu, Sorina Nicoleta
    Stan, Miriana
    Costache, Marieta
    Fenga, Concettina
    Drakoulis, Nikolaos
    Tsatsakis, Aristidis M.
    FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [43] Acriflavine enhances the antitumor activity of the chemotherapeutic drug 5-fluorouracil in colorectal cancer cells
    Zargar, Parisa
    Ghani, Esmaeel
    Mashayekhi, Farideh Jalali
    Ramezani, Amin
    Eftekhar, Ebrahim
    ONCOLOGY LETTERS, 2018, 15 (06) : 10084 - 10090
  • [44] Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma
    Leong, Swan Swan
    Wee, Joseph
    Rajan, Sandeep
    Toh, Chee Keong
    Lim, Wan Teck
    Hee, Siew Wan
    Tay, Miah Hiang
    Poon, Donald
    Tan, Eng Huat
    CANCER, 2008, 113 (06) : 1332 - 1337
  • [45] Spontaneous Aortic Haematoma in a Patient Receiving Adjuvant Folinic Acid, 5-Fluorouracil, Irinotecan, and Oxaliplatin Chemotherapy Following Resection of a Pancreatic Adenocarcinoma
    Dacie, Ruth
    Woodhouse, Laura
    Mullan, Damian
    Lamarca, Angela
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (10)
  • [46] A phase I trial of arterial infusion chemotherapy with gemcitabine and 5-fluorouracil for unresectable biliary tract cancer
    Hayashi, Tsuyoshi
    Ishiwatari, Hirotoshi
    Yoshida, Makoto
    Sato, Tsutomu
    Miyanishi, Koji
    Sato, Yasushi
    Kobune, Masayoshi
    Takimoto, Rishu
    Sonoda, Tomoko
    Kato, Junji
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2012, 17 (05) : 491 - 497
  • [47] Phase II trial of the use of gemcitabine and 5-fluorouracil in the treatment of advanced pancreatic and biliary tract cancer
    Murad, AM
    Guimaraes, RC
    Aragao, BC
    Rodrigues, VH
    Scalabrini-Neto, AO
    Padua, CAJ
    Moore, FC
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (02): : 151 - 154
  • [48] Cost-effectiveness of second-line treatment with irinotecan or infusional 5-fluorouracil in metastatic colorectal cancer
    Levy-Piedbois, C
    Durand-Zaleski, I
    Juhel, H
    Schmitt, C
    Bellanger, A
    Piedbois, P
    ANNALS OF ONCOLOGY, 2000, 11 (02) : 157 - 161
  • [49] A Multicenter Phase II Trial with Irinotecan plus Oxaliplatin as First-Line Treatment for Inoperable/Metastatic Cancer of the Biliary Tract
    Karachaliou, Niki
    Polyzos, Aris
    Kentepozidis, Nikolaos
    Kakolyris, Stylianos
    Ziras, Nikolaos
    Vardakis, Nikolaos
    Kalykaki, Antonia
    Milaki, Georgia
    Georgoulias, Vassilis
    Androulakis, Nikolaos
    ONCOLOGY, 2010, 78 (5-6) : 356 - 360
  • [50] A phase I trial of arterial infusion chemotherapy with gemcitabine and 5-fluorouracil for unresectable biliary tract cancer
    Tsuyoshi Hayashi
    Hirotoshi Ishiwatari
    Makoto Yoshida
    Tsutomu Sato
    Koji Miyanishi
    Yasushi Sato
    Masayoshi Kobune
    Rishu Takimoto
    Tomoko Sonoda
    Junji Kato
    International Journal of Clinical Oncology, 2012, 17 : 491 - 497